Salivary microbiome and serum metabolomics add to clinical biomarkers to predict 6-month hospitalizations in a multi-center cirrhosis outpatient cohort.

Journal:

Hepatology

Published:

2025-07-10

DOI:

10.1097/hep.0000000000001462

Affiliations:

15

Authors:

19

Go to article

Institutions	Authors	Share
George Mason University (GMU), United States of America (USA)	2.000000	0.11
Mayo Clinic, United States of America (USA)	2.000000	0.11
University of Toronto (U of T), Canada	2.000000	0.11
University of Washington (UW), United States of America (USA)	2.000000	0.11
Virginia Commonwealth University (VCU), United States of America (USA)	2.000000	0.11
VA Richmond Healthcare System, United States of America (USA)	2.000000	0.11
University of Alberta (U of A), Canada	2.000000	0.11
University of California, San Francisco (UCSF), United States of America (USA)	1.000000	0.05
Metabolon Inc., United States of America (USA)	1.000000	0.05
University of Pennsylvania (Penn), United States of America (USA)	1.000000	0.05
Yale University, United States of America (USA)	0.500000	0.03
West Haven VA Medical Center, United States of America (USA)	0.500000	0.03
The University of Texas Southwestern Medical Center (UT Southwestern Medical Center), United States of America (USA)	0.500000	0.03
Dallas VA Medical Center, United States of America (USA)	0.500000	0.03

Interested in Clinical Sciences?